Illumina To Webcast Upcoming Investor Conferences
Get Alerts ILMN Hot Sheet
Join SI Premium – FREE
SAN DIEGO, Feb. 3, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:
- SVB Leerink 2022 Global Healthcare Conference on February 17, 2022Fireside Chat at 9:00am Pacific Time (12:00pm Eastern Time)
- Citi 2022 Healthcare Conference on February 24, 2022Fireside Chat at 9:30am Pacific Time (12:30pm Eastern Time)
The live webcasts can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:Salli Schwartz+1.858.291.6421[email protected]
Media:Dr. Karen Birmingham+1.646.355.2111[email protected]
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conferences-301475244.html
SOURCE Illumina, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In Largest Study of Its Kind, U.S. Fiction Audiobook Consumers Rate Spoken Multi-Cast Higher Than Human Narration
- New Research Reveals Major Communication Gap Between Health Plans and New Mothers
- Heven AeroTech Expands Leadership Team to Scale Hydrogen-Powered UAS for Federal Defense Market
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Citi, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share